Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?

BACKGROUND/AIMS: Nonselective β-blockers (NSBBs), such as propranolol, reportedly exert a pleiotropic effect in liver cirrhosis. A previous report suggested that survival was higher in patients receiving adjusted doses of NSBBs than in ligation patients. This study investigated whether low-dose NSBB...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tae Wan, Kim, Hong Joo, Chon, Chang Uk, Won, Hyun Sun, Park, Jung Ho, Park, Dong Il, Cho, Yong Kyun, Sohn, Chong Il, Jeon, Woo Kyu, Kim, Byung Ik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415875/
https://www.ncbi.nlm.nih.gov/pubmed/22893871
http://dx.doi.org/10.3350/cmh.2012.18.2.203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415875/
https://www.ncbi.nlm.nih.gov/pubmed/22893871
http://dx.doi.org/10.3350/cmh.2012.18.2.203

Ejemplares similares